维普中文期刊产品整合服务
113篇 您的检索式:作者名="Fagan SC"
    题名 作者 年代 出处 被引量
1Clinical deterioration following impro- vement in the NINDS r-tPA stroke trial显示文摘Grotta JC Welch KM Fagan SC 2001Stroke2001,32,3:1
2Clinical deterioration for lowing improvement in the NINDS rt-PA Stroke Trial 显示文摘Grotta JC Welch KM Fagan SC 2001Stroke2001,32,3:1
3Minocycline to improve neurologic outcome in stroke (MINOS) : a dose-finding study显示文摘Fagan SC 2010Stroke2010,41,9:1
4Cost-effectivenessof tissue plasminogen activator for acuteischemic stroke 显示文摘Fagan SC Morgenstern LB Petitta A 1998Neurology1998,50,:1
5Minocycline developmentfor acute ischemic stroke显示文摘Fagan SC Cronic LE Hess DC 2011Transl Stroke Res2011,2,2:1
6Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment 显示文摘Ravina BM Fagan SC Hart RG 2003Neurology2003,60,:1
7Clinical deterioration following improvement in the NINDS rt-PA stroke trial显示文摘Grotta JC Welch KMA Fagan SC 2001Stroke2001,32,3:1
8Minocycline to improve neurologic outcome in stroke (MINOS) : a dose-finding study 显示文摘Fagan SC Waller JL Nichols FT 2010Stroke2010,41,:1
9Drug repurposing for vascular protec- tion after acute ischemic stroke 显示文摘Guan W Kozak A Fagan SC Acta Neurochir Suppl 20ll 1110,,:1
10Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment 显示文摘Ravina BM Fagan SC Hart RG 2003Neurology2003,60,8:1
11Clinical deterioration following improvement in the NINDS rt-PA stroke trial显示文摘 Welch KM Fagan SC 2001Stroke2001,32,:1
12Tactics for vascular pro- tection after ischemic stroke 显示文摘Fagan SC Hess DC Machado LS 2005Pharmacotherapy2005,25,3:1
13Targets for vascular protection after acute ischemic stroke显示文摘Fagan SC Hess DC Hohnadel EJ 0,,09:1
14New perspectives on the pharma-cotherapy of ischemic stroke显示文摘BradbrryJC Fagan SC Gray DR ei al 2004Am Pharm Assoc2004,44,:1
15Clinical deterioration following improvement in the VINDS rt-PA stroke trial显示文摘Grotta JC Welth KMA Fagan SC 2011Stroke2011,42,4:1
16Clinical deterioration following improvement in the Nindsrt Pastroke trial 显示文摘GrottaJC Welchk MA Fagan SC 2001Stroke2001,2,3:1
17Monoclonal antibodies preventing leukocyte acitivation reduce experimental neurologic injury and inhence efficacy of thromblytic therapy显示文摘Bowes MP Rothlein R Fagan SC 1995Neurology1995,45,4:1
18Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion- reperfusion in rats显示文摘Xu L Fagan SC Waller JL 2004BMC Neurol2004,4,:1
19New perspectives on thepharmacotherapy of ischemic stroke显示文摘Bradberry JC Fagan SC Gray DR 2004Jamharm Assoc2004,44,21:1
20Clinical deterioration following improvement in the NINDS rtPA Stroke Trial显示文摘Grotta JC Welch KM Fagan SC 2001Stroke2001,32,:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费